Brokerages Set Travere Therapeutics, Inc. (NASDAQ:TVTX) Target Price at $31.79
Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) has received an average recommendation of “Moderate Buy” from the fifteen research firms that are covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and thirteen have issued a buy recommendation on the company. The average twelve-month price objective among […]
Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) has received an average recommendation of “Moderate Buy” from the fifteen research firms that are covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and thirteen have issued a buy recommendation on the company. The average twelve-month price objective among […]
